Abstract
IntroductionRanitidine hydrochloride (Zantac®), a histamine-2-receptor antagonist, is a widely used medication with an excellent safety record. Anaphylactic reaction to ranitidine is an extremely rare event and a related death has never been described in the literature.Case presentationWe present the clinical history, histological and toxicological data of a 51-year-old man with negative anamnesis for allergic events, who died suddenly after the intravenous administration of one phial of Zantac® 50 mg prescribed as a routine post-surgical prophylaxis for stress ulcer.ConclusionAlthough the incidence of anaphylactic reactions related to ranitidine is low, caution needs to be exercised on administration of this drug. In addition, further study is needed to define strategies for the prevention of adverse drug reactions in hospitalized patients.
Highlights
Ranitidine hydrochloride (Zantac®), a histamine-2-receptor antagonist, is a widely used medication with an excellent safety record
Ranitidine hydrochloride (Zantac®) is a histamine-2receptor antagonist (H2RA) medication used in peptic ulcer disease therapy, acute stress ulcers, gastroesophageal reflux and related disorders
Ranitidine has an excellent safety record [2,3] and we found no reports of fatalities related to this drug in the literature, the incidence of anaphylactic reaction to H2RAs and proton pump inhibitors together has been reported as 0.3% to 0.7%
Summary
We have described the only fatal reaction related to ranitidine in the literature to date. Reactions to this extensively used drug are very rare in clinical practice. This case suggests that, the incidence of anaphylactic reactions related to ranitidine is low, caution needs to be exercised on administration of this drug. Further study is needed to define strategies for the prevention of ADRs in hospitalized patients. ADR: Adverse drug reaction; BPH: Benign prostatic hyperplasia; H2RA: Histamine-2-receptor antagonist
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.